科济药业：10月起已回购约331万股

Core Viewpoint - 科济药业-B (02171.HK) has announced an updated share repurchase plan, indicating a strategic move to enhance shareholder value through the buyback of shares [1] Group 1: Share Repurchase Details - Starting from November 13, 2025, the company plans to repurchase up to approximately 25.46 million shares within 50 trading days on the open market [1] - The total shares to be repurchased, including the approximately 3.31 million shares already bought back, will represent 5% of the total issued shares as of the authorization date for the 2025 share repurchase [1]